27 March 2019 : Clinical Research
Risk Factors Associated with Infusion Reactions to Infliximab in Chinese Patients with Inflammatory Bowel Disease: A Large Single-Center Study
DOI: 10.12659/MSM.913152
Med Sci Monit 2019; 25:2257-2264
HTML version available soon